{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670320707551232.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.3324/haematol.2009.008607"}}],"dc:title":[{"@value":"Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670320707551232","@type":"Researcher","foaf:name":[{"@value":"D. Ritchie"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320707551237","@type":"Researcher","foaf:name":[{"@value":"R. L. Piekarz"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320707551235","@type":"Researcher","foaf:name":[{"@value":"P. Blombery"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320707551238","@type":"Researcher","foaf:name":[{"@value":"L. J. Karai"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320707551240","@type":"Researcher","foaf:name":[{"@value":"S. Pittaluga"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320707551234","@type":"Researcher","foaf:name":[{"@value":"E. S. Jaffe"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320707551236","@type":"Researcher","foaf:name":[{"@value":"M. Raffeld"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320707551233","@type":"Researcher","foaf:name":[{"@value":"J. E. Janik"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320707551239","@type":"Researcher","foaf:name":[{"@value":"H. M. Prince"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320707551241","@type":"Researcher","foaf:name":[{"@value":"S. E. Bates"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"03906078"},{"@type":"EISSN","@value":"15928721"}],"prism:publicationName":[{"@value":"Haematologica"}],"dc:publisher":[{"@value":"Ferrata Storti Foundation (Haematologica)"}],"prism:publicationDate":"2009-07-16","prism:volume":"94","prism:number":"11","prism:startingPage":"1618","prism:endingPage":"1622"},"reviewed":"false","createdAt":"2009-07-17","modifiedAt":"2011-08-04","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360565168116348928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"JSH Guidelines for the Management of Hepatitis B Virus Infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567185479120640","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinical evaluation of a novel and highly sensitive immunoassay for anti‐hepatitis B core antigen using a fully automated immunochemical analyzer"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679252751872","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"ロミデプシン（イストダックス<sub>®</sub>点滴静注用10 mg）の薬理学的／薬物動態学的特性および臨床試験成績"},{"@language":"en","@value":"Romidepsin (Istodax<sub>®</sub> for intravenous injection 10 mg): pharmacokinetics, pharmacodynamics and clinical study outcome"},{"@value":"ロミデプシン(イストダックス点滴静注用10mg)の薬理学的/薬物動態学的特性および臨床試験成績"},{"@language":"ja-Kana","@value":"ロミデプシン(イストダックス テンテキ ジョウチュウヨウ 10mg)ノ ヤクリガクテキ/ヤクブツ ドウタイガクテキ トクセイ オヨビ リンショウ シケン セイセキ"},{"@value":"[Romidepsin (Istodax(R) for intravenous injection 10 mg): pharmacokinetics, pharmacodynamics and clinical study outcome], Nihon yakurigaku zasshi"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679771619840","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Two cases of acute hepatitis due to hepatitis E virus that are indigenous to Kitakyushu: a case report"},{"@language":"ja","@value":"北九州に土着したE型肝炎ウイルス株による急性肝炎の2例"},{"@value":"B型肝炎治療ガイドライン(第1.1版)"},{"@language":"ja-Kana","@value":"Bガタ カンエン チリョウ ガイドライン(ダイ1.1ハン)"},{"@language":"ja-Kana","@value":"キタキュウシュウ ニ ドチャク シタ Eガタ カンエンウイルスカブ ニ ヨル キュウセイ カンエン ノ 2レイ"},{"@value":"Guidelines for the management of hepatitis B virus infection"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.3324/haematol.2009.008607"},{"@type":"CROSSREF","@value":"10.1111/hepr.12269_references_DOI_SVQmd4AKoWmI1QHefCXQhR0FBZb"},{"@type":"CROSSREF","@value":"10.1111/hepr.13229_references_DOI_SVQmd4AKoWmI1QHefCXQhR0FBZb"},{"@type":"CROSSREF","@value":"10.2957/kanzo.54.402_references_DOI_SVQmd4AKoWmI1QHefCXQhR0FBZb"},{"@type":"CROSSREF","@value":"10.1254/fpj.151.122_references_DOI_SVQmd4AKoWmI1QHefCXQhR0FBZb"}]}